Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
Stopped The original PI on this study left VICC, thus study was closed.
Conditions
- Mucositis
- Multiple Myeloma and Plasma Cell Neoplasm
Interventions
- OTHER: laboratory biomarker analysis
Sponsor
Vanderbilt-Ingram Cancer Center
Collaborators